Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Pelthos Therapeutics Inc. (PTHS) had Debt to Capital Ratio of 0.59 for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$10.91M |
|
$-10.24M |
|
$1.67M |
|
$9.23M |
|
$23.99M |
|
$-13.09M |
|
$2.85M |
|
$-10.24M |
|
$-10.24M |
|
$-10.24M |
|
$-10.24M |
|
$-10.24M |
|
$-10.24M |
|
$-13.09M |
|
$-11.32M |
|
3.31M |
|
3.31M |
|
$-3.09 |
|
$-3.09 |
|
| Balance Sheet Financials | |
$69.80M |
|
$9.31M |
|
$75.58M |
|
$145.38M |
|
$25.00M |
|
$49.64M |
|
$85.27M |
|
$110.28M |
|
$35.10M |
|
$-28.02M |
|
$35.10M |
|
3.37M |
|
| Cash Flow Statement Financials | |
$-13.13M |
|
$-0.19M |
|
$27.52M |
|
$18.02M |
|
$32.23M |
|
$14.20M |
|
$1.91M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.79 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.59 |
1.41 |
|
84.66% |
|
-120.01% |
|
-120.01% |
|
-- |
|
-93.87% |
|
-93.87% |
|
$-13.32M |
|
-- |
|
-- |
|
-- |
|
0.07 |
|
0.07 |
|
0.93 |
|
96.55 |
|
-29.17% |
|
36.54% |
|
-7.04% |
|
-12.08% |
|
$10.42 |
|
$-4.02 |
|
$-3.96 |
|